Impact of Polyvascular Disease in Patients undergoing unprotected Left Main Percutaneous Coronary Intervention

Percutaneous coronary intervention (PCI) has demonstrated its safety and efficacy in treating left main coronary artery disease (LM-CAD) in select patients. Polyvascular disease (PolyVD) is associated with adverse events in all-comers with CAD. However, there is little data examining the interplay between PolyVD and LM-PCI, which we sought to investigate in a retrospective single-center study. We included patients undergoing unprotected LM-PCI at a tertiary center from 2012-2019. The patient population was stratified based on the presence or absence of PolyVD (i.e.

Source: The American Journal of Cardiology - April 30, 2024 Category: Cardiology Authors: Benjamin Bay, Raman Sharma, Anastasios Roumeliotis, David Power, Samantha Sartori, Jonathan Murphy, Birgit Vogel, Kenneth F Smith, Angelo Oliva, Amit Hooda, Joseph Sweeny, George Dangas, Annapoorna Kini, Prakash Krishnan, Samin K Sharma, Roxana Mehran Source Type: research